Project Details
Description
Engineered natural killer cells expressing chimeric CD64 as a cancer immunotherapy
Status | Finished |
---|---|
Effective start/end date | 7/1/18 → 6/30/19 |
Funding
- MN OVARIAN CANCER ALLIANCE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.